Email Sales

Email Sales

Need product support? Please visit our Customer Support page.





Back to Insights & Analysis

Pharma M&A for the First Half of 2014 Leaps Past 2013

BCIQ Deal Charts: First Half 2014 Highlights shows the year off to a strong start, with key details on global pharmaceutical sector M&A, partnerships and top areas of activity.

Get an overview of the pharmaceutical sector merger and acquisition deals that took place in the first six months of 2014. BCIQ Deal Charts: First Half 2014 Highlights includes a series of charts, developed by BioCentury Publications in association with Merrill Corporation, highlighting valuable data and observations. It calls out, for instance, how average product and technology deal size more than doubled over 2013 and which disease area saw as many deals in the first half of 2014 compared to all of 2013.

What’s covered:

  • M&A deals in 2014 compared to 2013, broken down by company size and disease category
  • Partnerships in 2014 compared to 2013, broken down by product and technology, stages at signing and disease category
  • Details on some of the largest deals, including the $2.1 billion partnership deal between Bayer and Merck & Co.

View Premium Content

Sign up once and access our entire library of premium content—white papers, webinars and reports—at any time.

All fields required*



I agree

This site uses cookies to offer you a better experience. For more information, view our privacy policy.